Related Experiment Video
Updated: Dec 19, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.0K
Statin use and myopathy. Not always guilty
Maria N Antoniol1, Pedro J Moreno2, José C Milisenda2
1Rheumatology Section, Internal Medicine Department, FLENI (Fundación para la Lucha Contra las Enfermedades Neurológicas de la Infancia), Buenos Aires, Argentina.
Rheumatology (Oxford, England)
|June 6, 2020
Summary
Not all muscle complaints in patients taking statins indicate statin-induced myopathy. A comprehensive evaluation is crucial to identify alternative diagnoses and ensure effective cardiovascular disease management.
Area of Science:
- Cardiology
- Neurology
- Endocrinology
Background:
- Statins are primary treatments for cardiovascular disease but can cause muscle-related side effects.
- Discontinuation of statins due to misdiagnosed myopathy can compromise cardiovascular health.
Observation:
- A study evaluated six patients referred for suspected statin-induced myopathy.
- These patients were assessed by myology experts in a specialized Muscular Diseases Unit.
Findings:
- Three patients had neurogenic causes, two had vacuolar myopathies, and one had severe hypothyroidism.
- Statin discontinuation occurred in two patients; one later received a PCSK9 inhibitor.
Implications:
- Accurate diagnosis of muscle complaints in statin users is essential.
- Thorough clinical assessment prevents unnecessary statin cessation and manages cardiovascular risk effectively.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.2K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
01:21Skeletal Muscle Relaxants: Adverse Effects
709
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
709
01:15Myasthenia Gravis: Diagnostic Tests
1.7K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.7K
01:20Myasthenia Gravis: Overview and Treatment
2.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K
01:14Myocarditis III: Medical Management
114
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
114
01:26Atherosclerosis III: Management
259
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
259